Blockade of protein kinase A (PKA) localization augments the trafficking and anti-tumor efficacy of adoptively transferred chimeric antigen receptor-expressing T cells

被引:0
|
作者
Newick, Kheng
O'Brien, Shaun
Sun, Jing
Kapoor, Veena
Maceyko, Steve
Lo, Albert
Pure, Ellen
Moon, Ed K.
Albelda, Steven M.
机构
关键词
D O I
10.1158/1538-7445.TME16-B27
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
B27
引用
收藏
页数:3
相关论文
共 50 条
  • [1] Enhancing the anti-tumor efficacy of chimeric antigen receptor-expressing T cells with naturally occuring plant stilbenes
    Soles, Andrea
    Richardson, Elle
    Barber, Amorette
    FASEB JOURNAL, 2019, 33
  • [2] Treatment of multiple myeloma with adoptively transferred chimeric NKG2D receptor-expressing T cells
    A Barber
    K R Meehan
    C L Sentman
    Gene Therapy, 2011, 18 : 509 - 516
  • [3] Treatment of multiple myeloma with adoptively transferred chimeric NKG2D receptor-expressing T cells
    Barber, A.
    Meehan, K. R.
    Sentman, C. L.
    GENE THERAPY, 2011, 18 (05) : 509 - 516
  • [4] Anti-tumor efficacy of chimeric NKG2D receptor-expressing T cells requires the induction of host immune responses
    Barber, Amorette
    Rynda, Agnieszka
    Zhang, Tong
    Sentman, Charles
    CANCER RESEARCH, 2009, 69
  • [5] Development of Chimeric Antigen Receptor-Expressing iPSC-Derived Macrophages with Improved Anti-Tumor Activity
    Pouyanfard, Somayeh
    Fierro, Manuel
    Skaufman, Dan
    BLOOD, 2021, 138
  • [6] Armed-Ad Gene Therapy Expressing PD-L1 Minibody Enhances the Anti-Tumor Effect of Adoptively Transferred Chimeric Antigen Receptor T-Cells for Solid Tumor Treatment
    Shaw, Amanda Rosewell
    Tanoue, Kiyonori
    Watanabe, Norihiro
    Porter, Caroline
    Brenner, Malcolm
    Suzuki, Masataka
    MOLECULAR THERAPY, 2016, 24 : S204 - S205
  • [7] Chimeric NKG2D receptor expressing T cells require host immune cells for anti-tumor efficacy
    Barber, Amorette
    Zhang, Tong
    Sentman, Charles L.
    FASEB JOURNAL, 2008, 22
  • [8] DNAX-activating protein 10 co-stimulation enhances the anti-tumor efficacy of chimeric antigen receptor T cells
    Zhao, Ruocong
    Cheng, Lin
    Jiang, Zhiwu
    Wei, Xinru
    Li, Baiheng
    Wu, Qiting
    Wang, Suna
    Lin, Simiao
    Long, Youguo
    Zhang, Xuchao
    Wu, Yilong
    Du, Xin
    Pei, Duanqing
    Liu, Pentao
    Li, Yangqiu
    Cui, Shuzhong
    Yao, Yao
    Li, Peng
    ONCOIMMUNOLOGY, 2019, 8 (01):
  • [9] Inducible secretion of IL-21 augments anti-tumor activity of piggyBac-manufactured chimeric antigen receptor T cells
    Stach, Martin
    Ptackova, Pavlina
    Mucha, Martin
    Musil, Jan
    Klener, Pavel
    Otahal, Pavel
    CYTOTHERAPY, 2020, 22 (12) : 744 - 754
  • [10] CRISPR/Cas9-Mediated Diacylglycerol Kinase Knockout Potentiates Anti-Tumor Efficacy of Human Chimeric Antigen Receptor T-Cells
    Jung, In-Young
    Kim, Yoon-Young
    Yu, Ho-Sung
    Kim, Seokjoong
    Thon, Jonathan N.
    Lee, Jungmin
    BLOOD, 2017, 130